Canagliflozin as a replacement therapy for patients with type 2 diabetes not responding to GLP-1 receptor agonists
2017
Diabetes & Metabolism - In Press.Proof corrected by the author Available online since mercredi 3 mai 2017
Keywords:
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI